首页 | 官方网站   微博 | 高级检索  
     

基质细胞衍生因子1及其受体与卵巢癌的关系研究进展
引用本文:张自辉,洪 莉.基质细胞衍生因子1及其受体与卵巢癌的关系研究进展[J].现代肿瘤医学,2022,0(22):4196-4199.
作者姓名:张自辉  洪 莉
作者单位:武汉大学人民医院妇产科,湖北 武汉 430060
基金项目:国家重点研发计划项目子课题(编号:2018YFC2002204)
摘    要:卵巢癌是常见的妇科恶性肿瘤,卵巢癌早期无特异性症状和体征,缺乏有效的诊断方法,超过70%的患者确诊时已属晚期,因此卵巢癌死亡率极高,预后差。基质细胞衍生因子1(stromal cell derived factor-1,SDF-1,CXCL12)及其受体CXCR4参与卵巢癌的增殖凋亡、侵袭转移以及血管新生,与卵巢癌的发生发展密切相关。本文综述了近年来卵巢癌中CXCL12/CXCR4的相关研究进展。

关 键 词:基质细胞衍生因子1  CXCR4  卵巢癌  靶向治疗

Research progress on the relationship between stromal cell-derived factor-1 and its receptors and ovarian cancer
ZHANG Zihui,HONG Li.Research progress on the relationship between stromal cell-derived factor-1 and its receptors and ovarian cancer[J].Journal of Modern Oncology,2022,0(22):4196-4199.
Authors:ZHANG Zihui  HONG Li
Affiliation:Department of Obstetrics and Gynecology,Renmin Hospital of Wuhan University,Hubei Wuhan 430060,China.
Abstract:Ovarian cancer is a common gynecological malignant tumor.Based on the lack of specific symptoms and signs in the early stage of ovarian cancer,and the lack of effective diagnostic methods,more than 70% of patients are already at an advanced stage when they are diagnosed.Therefore,the mortality rate of ovarian cancer is extremely high and the prognosis is poor.Stromal cell derived factor-1 (SDF-1,CXCL12) and its receptor CXCR4 are involved in the proliferation,apoptosis,invasion,metastasis,and angiogenesis of ovarian cancer,and are closely related to the occurrence and development of ovarian cancer.This article reviews the research progress of CXCL12/CXCR4 in ovarian cancer in recent years.
Keywords:stromal cell-derived factor-1  CXCR4  ovarian cancer  targeted therapy
本文献已被 维普 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号